The QualityStocks Daily Wednesay, June 5th, 2019

Today's Top 3 Investment Newsletters

RedChip (RWLK) +122.89%

Jason Bond (WKHS) +24.86%

QualityStocks (ALYE) +15.94%

The QualityStocks Daily Stock List

HIVE Blockchain Technologies Ltd. (HVBTF)

Micro Small Cap, TipRanks, Blockchain Stocks, FXStreet, Smarter Analyst, Crypto141, Dividend Investor, Wallmine, Investors Hangout, YCharts, Invest Tribune, Stockwatch, 4-Traders, Market Screener, Trading View, Insider Financial, Stockhouse, Simply Wall St, and InvestorsHub reported previously on HIVE Blockchain Technologies Ltd. (HVBTF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

HIVE Blockchain Technologies Ltd. is a company building a bridge from the blockchain sector to traditional capital markets. It is strategically partnered with Genesis Mining Ltd. to build the next generation of blockchain infrastructure. HIVE’s mission is to expedite the development of the blockchain sector through traditional capital markets and create long-term shareholder value. OTCQX-listed, HIVE Blockchain Technologies is based in Vancouver, British Columbia.

HIVE’s deployments provide shareholders with exposure to the operating margins of digital currency mining and a growing portfolio of crypto-coins. The Company owns state-of-the-art GPU-based digital currency mining facilities in Iceland and Sweden, which produce newly minted digital currencies such as Ethereum continuously and also a cloud-based ASIC-based capacity that produces newly minted digital currencies such as Bitcoin.

HIVE Blockchain Technologies has an exclusive arrangement with Genesis Mining to operate its data centers under a Master Service Agreement. The data centers will be monitored with Genesis Hive, which is Genesis Mining's proprietary software tool for large-scale mining, to automatically optimize chip temperatures and power consumption for maximal coin production.

Concerning the Iceland Cryptocurrency Mining Project, HIVE’s launch transaction involved the acquisition of an initial state-of-the-art blockchain infrastructure facility in Iceland from Genesis Mining. The facility produces mined cryptocurrency around the clock. Assembly of the facility, which uses unique computing components and infrastructure design, was completed in May 2017. In Sweden, HIVE's GPU facilities were completed in April 2018. They are equipped with custom Genesis A2 mining rigs.

On December 1, 2018, HIVE Blockchain Technologies launched the operation of an additional 100 PH of cloud-based ASIC Bitcoin mining This brings its digital currency mining footprint to a total of 24.2 MW of GPU mining and 300 PH of ASIC capacity.

Recently, HIVE Blockchain Technologies announced that it entered into a non-binding letter of intent (LOI) and heads of terms and a share swap agreement with Argo Blockchain PLC (ARB.L) to explore a proposed strategic partnership to form the world's largest business-to-business (B2B) mining service provider aimed at large-scale enterprise and institutional customers. The proposed strategic partnership will enable all miners to benefit from the combination of the two groups' existing mining capacity. This includes part of HIVE's equivalent mining capacity of 45 megawatts (MW) and Argo Blockchain's 10.5MW capacity. Additionally, it presents a major opportunity to service strategic institutional clients that require Mining-as-a-Service (MaaS) infrastructure to mine virgin coins from safe jurisdictions such as North America and Europe.

HIVE Blockchain Technologies Ltd. (HVBTF), closed Wednesday's trading session at $0.385, up 8.55%, on 737,104 volume with 162 trades. The average volume for the last 3 months is 581,592 and the stock's 52-week low/high is $0.17/$0.893.

chart

Ucore Rare Metals, Inc. (UURAF)

Streetwise Reports, Micro Small Cap, Street Register, Trading View, Marketbeat, Wallet Investor, Northern Miner, and Stockhouse reported earlier on Ucore Rare Metals, Inc. (UURAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Ucore Rare Metals, Inc. engages in the exploration and separation of rare earth elements in Canada and the U.S. Ucore is a development-phase company centered on rare metals resources, extraction and beneficiation technologies with near term potential for production, growth and scalability. The Company has a 100 percent ownership stake in Bokan-Dotson Ridge (Bokan). Bokan is the highest grade heavy rare earth project within the U.S. based on NI 43-101 standards. Ucore Rare Metals is based in Nova Scotia, Canada.

The Company’s vision and plan is to transition to become a foremost nanotechnology company that provides mineral separation products and services to the mining and mineral extraction industry. Its vision includes the development of a Strategic Metals Complex in Ketchikan, Alaska and the development of its rare earth minerals property at Bokan Mountain in Alaska.

Ucore Rare Metals announced, on March 31, 2014, the unanimous support of the Alaska State Legislature for Senate Bill 99 (2014) that authorized the AIDEA to issue up to USD $145 Million in bonds for the infrastructure and construction costs of the Bokan-Dotson Ridge Rare Earth Project. The Bokan Project is the Company’s main emphasis. The Project is 60 km southwest of Ketchikan, Alaska and 140 km northwest of Prince Rupert, British Columbia. It has direct ocean access to the western seaboard and the Pacific Rim.

Regarding Ucore’s SuperLig®-One pilot plant project, it has been engineered to accept a Pregnant Leach Solution (PLS). The initial output products are carbonate salts of the critical rare earth elements dysprosium, europium and terbium derived from the Bokan Dotson-Ridge Heavy REE Project in Southeast Alaska.

Regarding the Ray Mountains, Alaska Project, Ucore Rare Metals, through a wholly-owned operating subsidiary, holds claims on land selected for its mineral resource potential by the State of Alaska as part of the State’s land entitlement under the 1958 Alaska Statehood Act. The Company is planning expanded exploration once title transfer is tentatively approved by the federal government.

Ucore Rare Metals, Inc. (UURAF), closed Wednesday's trading session at $0.1398, down 8.27%, on 312,250 volume with 86 trades. The average volume for the last 3 months is 212,642 and the stock's 52-week low/high is $0.065/$0.25.

chart

Windtree Therapeutics, Inc. (WINT)

Small Cap Network, Earnings Whispers, Emerging Growth, Marketbeat, Stockwatch, MarketWatch, Stockhouse, Wallmine, Market Screener, Wallet Investor, Zacks, Real Investment Advice, and Investors Place reported earlier on Windtree Therapeutics, Inc. (WINT), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

A biotechnology and medical device company, Windtree Therapeutics, Inc. concentrates on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases. It has four clinical and multiple pre-clinical programs in respiratory, cardiovascular and oncology disease states. The Company was previously known as Discovery Laboratories, Inc. It changed its name to Windtree Therapeutics, Inc. in April of 2016. OTCQB-listed and established in 1992, the Company is headquartered in Warrington, Pennsylvania.

Windtree Therapeutics’ lead clinical programs include AEROSURF®, Istaroxime, and Rostafuroxin. AEROSURF is undergoing development for neonatal intensivists treating premature infants diagnosed with respiratory distress syndrome (RDS). AEROSURF is an inventive, med-device combination designed for the non-invasive delivery of its proprietary KL4 synthetic, peptide-containing surfactant into the lungs of neonates using a unique Aerosol Delivery System (ADS).

Istaroxime is undergoing development for cardiologists and other hospital-based providers treating patients diagnosed with acute decompensated heart failure. With istaroxime, Windtree is at the Vanguard of developing a first-in-class, dual acting agent designed to improve the systolic and the diastolic function of the heart. This is while avoiding the often rate-limiting side effects of existing treatments. In phase 2 clinical trials, istaroxime demonstrated significant physiologic improvements. This included improved cardiac function and increased blood volume ejected with each beat.

Rostafuroxin is undergoing development as a novel precision medicine targeting hypertensive patients with certain genetic profiles centered on the large and important resistant hypertension market. Rostafuroxin has the potential to be an important novel target therapy for patients with the suitable genetic profile. Windtree is concentrating on finalizing an enhanced formulation, analytic measures and assessments. It subsequently plans to conduct business development to out-license rostafuroxin to a larger pharmaceutical company that has expertise and infrastructure in the very large and broad antihypertension market.

Last week, Windtree Therapeutics announced the presentation of new safety and efficacy data from a phase 2b study of istaroxime in patients hospitalized with acute heart failure (AHF) at a late-breaker session of the European Society of Cardiology (ESC) 2019 Heart Failure Congress. The study realized its primary endpoint by demonstrating a significant improvement (0.05) in cardiac function at both istaroxime study doses. The study further showed that stroke volume, a key secondary endpoint, was considerably increased. Certain toxicities and complications experienced with many existing acute heart failure therapies were not observed in istaroxime-treated patients.

Yesterday, Windtree Therapeutics and Eleison Pharmaceuticals LLC jointly announced positive results of the feasibility study using Windtree's proprietary Aerosol Delivery System (ADS) aerosolization technology to deliver Eleison's inhaled lipid cisplatin (ILC). The feasibility assessment demonstrated that Windtree's ADS technology can effectively aerosolize ILC and at a higher volume versus conventional nebulizer technology. In the feasibility study, the ADS technology produced in 20 minutes about the same volume of aerosolized ILC that required roughly two hours to produce in a phase 2 clinical trial treating osteosarcoma lung metastases with ILC delivered by conventional nebulizer technology. Eleison Pharmaceuticals is a specialty pharmaceutical company developing life-saving therapeutics for rare cancers.

Windtree Therapeutics, Inc. (WINT), closed Wednesday's trading session at $4.50, even for the day, on 1,150 volume with 9 trades. The average volume for the last 3 months is 1,728 and the stock's 52-week low/high is $0.51/$0.10.

chart

American Hotel Income Properties REIT LP (AHOTF)

Morningstar, Stockhouse, Stockwatch, Stock Target Advisor, Marketbeat, Wallmine, OTC Markets, and Wallet Investor reported earlier on American Hotel Income Properties REIT LP (AHOTF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

American Hotel Income Properties REIT LP, or AHIP, is a limited partnership created to invest in hotel real estate properties located in the U.S. AHIP hotels operate under brands affiliated with Marriott, Hilton, IHG, Wyndham and Choice Hotels by way of license agreements. AHIP’s long-term goals are to build on its proven track record of successful investment, deliver reliable and consistent U.S. dollar denominated distributions to unitholders, and generate value via the continued growth of its diversified hotel portfolio. AHIP lists on the OTC Markets’ OTCQX. The Company is based in Vancouver, British Columbia.

At present, AHIP has 112 hotels. It is engaged in growing its portfolio of premium branded, select-service hotels in larger secondary markets that have diverse and stable demand. The Company is led by an experienced management team consisting of proven hotel industry leaders, including award-winning entrepreneurs and executives.

AHIP seeks out properties distinguished by stabilized in-place income; and an all-in trailing capitalization rate greater than 8 percent; as well as acquisition cost below replacement cost; and strong demand generators. It also seeks out properties with limited new supply; that complement existing premium branded, Select-Service hotels; and targeted geographic diversification within the U.S. Consistent with its acquisition strategy, all properties are strategically located within or near larger population centers, transportation corridors, and demand generators.

Last month, AHIP announced its financial results for the three months ended March 31, 2019. Mr. John O'Neill, Chief Executive Officer, said, "Our first quarter results demonstrate the hotels we renovated in 2018 are now commanding higher guestroom rates, generating substantially more food and beverage revenues, and driving higher margins. The six hotels that were renovated by the end of January collectively saw first quarter ADR grow 3 percent and revenue grow nearly 7 percent compared to the same period of 2018. The strong contribution from these newly updated hotels was partially offset by the impacts of ongoing renovations during the quarter, which compressed occupancy rates for our portfolio."

Recently, AHIP announced a cash distribution of US$0.054 per limited partnership unit for the period of May 1, 2019 to May 31, 2019. This is equivalent to US$0.648 per Unit on an annualized basis. The distribution will be paid on June 14, 2019 to unitholders of record at the close of business on May 31, 2019.

American Hotel Income Properties REIT LP (AHOTF), closed Wednesday's trading session at $4.9861, up 0.16%, on 5,422 volume with 14 trades. The average volume for the last 3 months is 12,398 and the stock's 52-week low/high is $4.34/$7.22.

chart

Delrey Metals Corp. (DLRYF)

Micro Small Cap, Streetwise Reports, Stock Target Advisor, Street Signals, Geology for Investors, Investing News, InvestorsHub, Mining Stock Education, Stockhouse, Stockwatch, Investorx, Investor Ideas, and Junior Mining Network reported earlier on Delrey Metals Corp. (DLRYF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

A mineral exploration company, Delrey Metals Corp. is working to capitalize on the growing demand for Energy Metals. The Company is focusing on the acquisition, exploration and development of mineral resource properties, specifically in the strategic energy minerals space. It has an option to earn an 80 percent interest in the Four Corners Project located in Newfoundland & Labrador. Delrey continues to review and acquire projects showing potential for materials used in the energy storage and electric vehicle markets. Delrey Metals lists on the OTC Markets and the Company is based in Vancouver, British Columbia.

Delrey Metals’ Four Corners Project is an advanced stage Fe-Ti-V exploration project. It has positive historic drilling, metallurgy, as well as development economics. In addition, Delrey recently acquired the Star, Porcher, Peneece and Blackie Fe-Ti-V properties situated along tidewater in western British Columbia.

The Four Corners Project consists of 7655.0 hectares and is positioned in southwestern Newfoundland and Labrador, 25km east of the town of Stephenville. The Project is host to vanadium enriched titaniferous magnetite (iron) mineralization that shows encouraging historical evidence for considerable and consistent vanadium accumulations across five main target zones.

The Blackie vanadium property is located in west-central British Columbia, in the Skeena Mining Division, about 96km south-southwest (straight-line distance) from Prince Rupert. The property comprises 5 tenures encompassing 1213.2 Ha. It is open for expansion in numerous directions. The Peneece vanadium project is situated at the head of Seymour Inlet, southwest British Columbia, The property comprises 5 tenures covering 1500.4 Ha. It is also open for expansion in multiple directions. The Porcher vanadium property is in west-central British Columbia, in the Skeena Mining Division. The property comprises 7 tenures encompassing 3122.16 Ha. It is open for expansion in manifold directions.

The Star property is located in west-central British Columbia, in the Skeena Mining Division. This property comprises 4 tenures encompassing 3646.8 Ha and is open for expansion in multiple directions. Moreover, the Sunset Project had historical drilling done in 1991 and it totaled 393.5m over 2 holes. The target currently sought at the Sunset claims is a volcanogenic massive sulphide deposit, similar to Britannia or a vein and replacement type gold-silver deposit similar to Northair or Brandywine.

Today, Delrey Metals provided a corporate update regarding 2019 exploration activities on its flagship Fe-Ti-V Four Corners Project Stephenville, Newfoundland and Labrador, and also its wholly-owned Peneece property near Port Hardy, British Columbia. The Company is to complete up to 5,000m of drilling over a proposed 20 drill holes, and 1,600m of trenches on the Four Corners Project during the 2019 exploration season. Work will focus on the Keating Hill East, Four Corners, and Bullseye Zones.

The design of 2019 drilling is to complete infill and step out drill targets as necessary to advance project towards a maiden NI 43-101 resource calculation. 2012 initial SRK Consulting (Canada) Inc.'s metallurgical results returned a magnetic concentrate grading 63.10% Fe, and 0.643% V205, and also a low intensity magnetic concentrate returning a notable 26.80% Ti02, at an 80% recovery. Furthermore, Delrey has completed a Phase I airborne geophysics survey across its wholly-owned Fe-Ti-V Peneece property located near Port Hardy, British Columbia.

Delrey Metals Corp. (DLRYF), closed Wednesday's trading session at $0.10854, up 3.37%, on 101,723 volume with 32 trades. The average volume for the last 3 months is 54,745 and the stock's 52-week low/high is $0.086/$0.30.

chart

Astro Aerospace Ltd. (ASDN)

Capital Market Review, Stock Talk Today, Small Cap Exclusive, Street Insider, Marketbeat, Teletrader, Real Investment Advice, Wallet Investor, Stockhouse, and Stockwatch reported previously on Astro Aerospace Ltd. (ASDN), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Astro Aerospace Ltd. creates autonomous, eVTOL (Electric Vertical Takeoff and Landing) aerial vehicles and drones. Its corporate mission is to make self-flying unmanned and manned vehicles available to anyone, at anytime, from anywhere, and to turn this aircraft into a mainstream mode of transportation. Astro Aerospace lists on the OTC Markets Group’s OTCQB.

The Company is headquartered in Lewisville, Texas. It previously went by the name CPSM, Inc. It changed its name to Astro Aerospace Ltd. in March of 2018. The Astro Canadian Development Facility is in Toronto, Ontario.

Astro Aerospace is the only public pure play company worldwide that has a functioning technology in a working, full-scale prototype. Astro’s solution is to commercialize its technology and sell it to the government and private sectors. This is so it can be used for military operations, search and rescue, commercial deliveries, sight-seeing, personal flight, and more.

At present, Astro Aerospace has a working prototype, which features a carbon fibre shell, and 16 independent rotors to enable flight. In the cockpit is a touch control system. It enables pilots to fly manually or switch to autonomous mode. The Company foresees the vehicle to be used across an array of industries. This is from personal, to agricultural to military uses and many in between.

Astro Aerospace is taking steps to protect its valuable intellectual property (IP) through the filings of suitable patent applications, design applications and trademark applications. Taking into consideration its soon to be revealed Modular System and new prototype design launch, the Company has taken steps to protect its designs, naming rights and the proprietary control systems that have demonstrated industry leading flight capabilities.

Scheduled for late Summer 2019, Astro Aerospace is planning the unveiling of its new Modular design platform and upgraded control systems. This includes its triple redundancy capabilities, improved flight time, speed and payload capacity and also its new battery management system, among others.

The new modular system will complement the Company’ present model, “Elroy”, it’s 2 passenger, eVTOL (Electric Take Off and Landing) short haul aerial vehicle. Elroy has the ability to travel up to 70km/hr for 25 minutes completely emission free.

                   

Astro Aerospace Ltd. (ASDN), closed Wednesday's trading session at $0.31, down 3.09%, on 172,145 volume with 67 trades. The average volume for the last 3 months is 128,323 and the stock's 52-week low/high is $0.221/$3.33.

chart

Dthera Sciences (DTHR)

NetworkNewsWire, Internet Bull Report, Stockopedia, PR Newswire, Stockhouse, Trial Site News, InvestorsHub, Accesswire, Investors Hangout, Stockwatch, Wallet Investor, Market Screener, Dividend Investor, and Trading View reported earlier on Dthera Sciences (DTHR), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Dthera Sciences is the leading digital therapeutic company focusing on the elderly. It specializes in neurodegenerative diseases. The Company is working to improve the lives of seniors and individuals suffering from neurodegenerative diseases, and also those who care for them. Dthera is developing DTHR-ALZ, a medical device. Dthera Sciences’ shares trade on the OTCQB. The Company is based in San Diego, California.

In December 2018, Dthera Sciences announced that the U.S. Food and Drug Administration (FDA) informed Dthera that it believes that a De Novo submission is the most suitable regulatory pathway for DTHR-ALZ, as Dthera Sciences had proposed. DTHR-ALZ is a medical device that has been granted Breakthrough Device designation by the FDA for the mitigation of the symptoms of agitation and depression associated with Alzheimer's disease. If granted clearance by the FDA, DTHR-ALZ would become the first non-pharmacological prescription treatment for the symptoms of Alzheimer's disease.

The DTHR-ALZ device digitally delivers an evidence-based behavioral intervention called Reminiscence Therapy to individuals with Alzheimer's disease. DTHR-ALZ is not yet cleared by the U.S. Food and Drug Administration (FDA), and is not yet available for commercial use in the United States.

DTHR-ALZ consists of three key components. One is a custom computer tablet specifically designed and tested for seniors with Alzheimer’s disease. The second is a facial expression detection system to assess the reaction to reminiscence content. The third component is a two sided AI that obtains and optimizes therapeutic content being delivered to the patient.

Recently, Dthera Sciences announced that it entered into an exclusivity agreement with a company based in Japan for development and commercialization rights to Dthera's lead product, DTHR-ALZ. The exclusivity agreement provides exclusive rights to the Japanese partner to perform feasibility studies in Japan and to negotiate a licensing agreement or other transaction for the Japanese market during the agreed term. In consideration for the exclusive review and negotiation period, the Japanese partner has paid Dthera Sciences a non-refundable cash payment.

Earlier this month, Dthera Sciences announced that its Board of Directors began a process to pursue a range of potential strategic transactions to enable Dthera to bring its development-stage Alzheimer's product, DTHR-ALZ, to market faster. These structures include a funded partnership on DTHR-ALZ, an acquisition of Dthera Sciences, a business combination, or strategic investment/financing into the Company.

Dthera Sciences has been in early-stage discussions with a number of third-party entities relating to a licensing partnership or acquisition. The Company has also been approached regarding business combination transactions. Dthera has elected to formalize the process by announcing its goal of finding a commercialization partner.

Dthera Sciences (DTHR), closed Wednesday's trading session at $0.90, up 2.27%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 828 and the stock's 52-week low/high is $0.50/$16.79.

chart

The American Energy Group, Ltd. (AEGG)

Penny Stock Tweets, Stockwatch, Dividend Investor, Real Investment Advice, InvestorsHub, Research Gate, Zacks, Stockhouse, 4-Traders, GuruFocus, The Street, MarketWatch, Wallet Investor, Marketbeat, Market Screener, and Business Wire reported beforehand on The American Energy Group, Ltd. (AEGG), and today we report on the Company, here at the QualityStocks Daily Newsletter. 

The American Energy Group, Ltd.  (AEGG)  is an energy resource royalty company listed on the OTC Markets. It is a non-operating oil and gas enterprise. The Company has an 18 percent  gross overriding royalty interest on the producing Yasin Block 2468-7 in South-Central Pakistan that comprises 172 acres. AEGG  has its corporate office  in Westport, Connecticut.

The Company’s strategy is to expand its portfolio of royalty and convertible Working Interests (WIs) in long-term petroleum leases. Additionally, its strategy is to create shareholder value through investing in exploration and early development projects with high cash-flow potential. AEGG’s focus will be high-impact South Asia energy development opportunities that are characterized by manifold target structures and locations with a potential for considerable hydrocarbon reserves.

AEGG’s other core assets comprise royalties and convertible carried WI’s in oil and gas leases. These include a  2.5 percent carried WI in Zamzama North Block No. 2667-8 under exploration  in South-Central, Sindh Province, Pakistan. Heritage Oil and Gas is the operator. This property consists of 557,951 square acres.

In addition, in the Zamzama North and Sanjawi Blocks, AEGG has the option to convert its 2.5 percent  carried WI’s at any time, on a well by well basis to a 1.5 percent  royalty, free of the costs of exploration  and development of the leases.  The convertible carried  WI  is "carried", which means  free of exploration and development costs,  as to the first  three wells for Zamzama North, and the first two wells for Sanjawi.
 
Furthermore, AEGG has a 2.5 percent carried WI in Sanjawi Block No. 3068-2 under exploration in North-Central, Baluchistan Province, Pakistan. Heritage Oil and Gas is the operator. This property is 302,895 square acres. The other joint venture (JV) partners are Hycarbex-American Energy, Inc, Sprint Energy, and Trakker Energy.

In May of 2018, AEGG announced that the Government of Pakistan granted to the Company's wholly-owned subsidiary, Hycarbex-American Energy an extension to the Yasin Exploration License relating back to the date of the request for extension in March of 2013. Company Management promptly started its plans for exploration and development activities on the Yasin Exploration License based on this extension. 

The American Energy Group, Ltd. (AEGG), closed Wednesday's trading session at $0.05, up 38.89%, on 22,500 volume with 2 trades. The average volume for the last 3 months is 9,681 and the stock's 52-week low/high is $0.025/$0.14.

chart

Trutankless, Inc. (TKLS)

Amigo Bulls, Dividend Investor, Market Screener, OTC Markets, Street Insider, Last10k, MarketWatch, Investors Hangout, Insider Tracking, Stocks News Feed, Oilandgas360, InvestorsHub, PR Newswire, The Street, Trading View, Canadian Insider, Zacks, 4-Traders, Morningstar, GuruFocus, Wallet Investor, Barchart, Simply Wall St, and Capital Cube reported on Trutankless, Inc. (TKLS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Trutankless, Inc. is a technology-driven developer of accessible, next-generation home automation and efficiency systems. Its main products are a line of electric tankless water heaters, which exceed traditional tank water heaters in energy efficiency, output, dependability and environmental sustainability. Established in 2008, Trutankless has its corporate headquarters in Scottsdale, Arizona. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Fundamentally, the Company’s vision is to modernize tankless water heating through promoting energy conservation and long term savings with its pioneering product for the benefit of homeowners, service professionals and consumers. Regarding the Trutankless Smart Unit, it has a Touchscreen LCD display with Wi-Fi connectivity, built-in safety features, adjustable power management and temperature settings. It has built in breakers for added safety and custom stainless alloy elements that operate more efficiently.

The custom heat exchanger uses patent pending Velix technology and ceramic thermal insulation. The flow meter produces hot water at a consistent temperature within 1 degree.

Trutankless sells its products to plumbing wholesale distributors and dealers throughout the United States. Working together with its manufacturing partner, Taiwan-based, SINBON Electronics, in Q3-2018 Trutankless completed phase one of its new manufacturing capabilities. This considerably expands the Company’s volume capacity to a thousand units per month.

Trutankless expanded its national active wholesaler mark from 165 locations at the start of 2018 to more than 1,000 wholesaler locations by the end of the year. The Company has national partnerships with groups such as Mr. Rooter, and relationships with Benjamin Franklin and RotoRooter.

Trutankless established new partnerships with a number of nationally recognized plumbing and installation organizations including Service Experts, and numerous dominant regional companies in target markets. This year, the Company’s goal is to focus additional attention and resources to the national launch of its wholesale market footprint, working to maintain the thrust of the sales volume in this channel.

Trutankless, Inc. (TKLS), closed Wednesday's trading session at $0.68, up 27.10%, on 16,650 volume with 9 trades. The average volume for the last 3 months is 5,731 and the stock's 52-week low/high is $0.30/$1.12.

chart

Fortescue Metals Group Limited (FSUMF)

Trading View, The Street, MarketWatch, Investor Village, Wallet Investor, Marketbeat, Equity Clock, 4-Traders, Morningstar, OTC Markets, Current Charts, InvestorsHub, YCharts, and Dividend Investor reported earlier on Fortescue Metals Group Limited (FSUMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQX-listed, Fortescue Metals Group Limited is a global leader in the iron ore industry. The Company has grown to be one of the largest international iron ore producers. Currently, Fortescue produces 170 million tonnes of iron ore per annum. Fortescue Metals Group is based in East Perth, Western Australia.

Fortescue is the first company in Western Australia to control a railway from outside an area of operation. It wholly owns and operates its purpose designed rail and port facilities. The Company’s railway covers 620 kilometers of track. In addition, Fortescue is the first company worldwide to use CAT autonomous haulage technology on a commercial scale.

Fortescue Metals continues to undertake early stage, low cost exploration on coppergold prospective tenements in South Australia and New South Wales. Furthermore, the Company has assessed high potential, early stage exploration tenements in Ecuador, where it was granted 32 exploration areas.

Fortescue owns and operates integrated operations encompassing three mine sites in the Pilbara, the five berth Herb Elliott Port in Port Hedland, and the fastest, heavy haul railway in the world. At present, the Company supplies 17 per cent of China’s seaborne iron ore.

The Company has expanded autonomous haulage at Chichester Hub. The expansion of its autonomous haul fleet has marked a significant milestone, with the first trucks fitted with Autonomous Haulage Technology (AHS) now in operation at Christmas Creek. The Chichester Hub in the Chichester Ranges, comprising the Cloudbreak and Christmas Creek mines, has an annual production capacity of 100mtpa from three Ore Processing Facilities (OPF). The conversion of about 100 haul trucks at the Chichester Hub will see Fortescue Metals become the first iron ore operation globally to have a fully autonomous fleet.

Fortescue Metals has its Iron Ore Projects. Its Iron Bridge Project is 100 kilometers south of Port Hedland. This is a JV between Fortescue Metals Group, Taiwan’s Formosa Group, and China’s Baosteel Group, incorporating the world class North Star and Glacier Valley Magnetite ore bodies. Moreover, Fortescue’s Iron Ore Projects include the Firetail Replacement Project. Firetail is an important aspect of the Fortescue Blend product.

Fortescue’s operations include The Solomon Hub in the Hamersley Ranges. The Solomon Hub is 60 kilometers north of Tom Price and 120 kilometers to the west of Fortescue Metals’ Chichester Hub.

In South America, the Company continues to assess exploration and development opportunities throughout, including Ecuador, Colombia and Argentina. Thirty-two exploration concessions were awarded in Ecuador and initial evaluation of potential for porphyry copper deposits began. A further 64 applications were lodged in Colombia for exploration concessions in areas that are copper and gold prospective.

Fortescue Metals Group Limited (FSUMF), closed Wednesday's trading session at $5.48, up 0.55%, on 4,500 volume with 2 trades. The average volume for the last 3 months is 7,600 and the stock's 52-week low/high is $2.53/$6.43.

chart

CanAlaska Uranium Ltd. (CVVUF)

Equity Clock, Dividend Investor, Morningstar, Stockhouse, Streetwise Reports, OTC Markets Group, InvestorsHub, Resource World, last10k, FeedBlitz, GuruFocus, Wallet Investor, and MarketWatch reported earlier on CanAlaska Uranium Ltd. (CVVUF),  and today we report on the Company, here at the QualityStocks Daily Newsletter. 

CanAlaska Uranium Ltd. is an exploration stage enterprise listed on the OTCQB. The Company focuses on two important projects in the Athabasca Basin in the Province of Saskatchewan. It holds interests in about 102,870 hectares (254,000 acres), one of the largest land positions in Canada's Athabasca Basin region. A project generator, CanAlaska Uranium has its head office in Vancouver, British Columbia. 

  The Company’s strategic holdings have attracted major international mining companies. Currently, CanAlaska Uranium is working with Cameco and Denison at two of CanAlaska’s properties in the Eastern Athabasca Basin.

  CanAlaska’s projects include Cree East, West McArthur, NW Manitoba, and base metals and gold projects and other uranium projects as well as its diamond projects. The Cree East project is a high-priority property situated in the southeastern portion of the Athabasca Basin.

  The West McArthur project is adjoining the world’s richest uranium mine -Cameco's McArthur River. The objective at West McArthur is a large unconformity uranium deposit.  Moreover, $20 million of work successfully identified seven target areas. The NW Manitoba project lies in northwest Manitoba just east of the border of northeast Saskatchewan. It is 70 kilometers north of Reindeer Lake.

CanAlaska acquired four new claims groups in the western Athabasca Basin for diamond exploration. Three of these are in the region just north of current claims in the Patterson Lake area.

The Company has new targets developed at the Thompson Nickel Belt Properties. In Manitoba, CanAlaska has continued Project Generation activities, with licence acquisitions in the Thompson Nickel Belt. Compilation work has continued. More targets have been developed on the Strong and Hunter properties.

Last month, CanAlaska Uranium reported that plans have been made for drill testing of the northern portion of Grid 5, where Cameco identified multiple intercepts of uranium mineralization in the most recent drill programs. Under the Joint Venture (JV) with Cameco, CanAlaska Uranium will act as Operator and plans to drill 7000 meters in 10 drill holes in summer 2019 to endeavor to intersect lenses of higher-grade uranium mineralization.

Last week, CanAlaska Uranium reported on successful completion of drilling at Manibridge, Manitoba. Four holes showed semi-massive and massive sulphide mineralization with associated wider zones of disseminated sulphides near existing mineralization. The four hole, 1,000 meter drill program successfully intercepted a wide fold structure, 2.5 kilometers north of the past-producing high-grade Manibridge nickel mine.

Nickel mineralization was intersected in all holes. In each case a zone of massive sulphides, 0.5 to 4 meters long in drill holes, is hosted by a wide zone of disseminated sulphide mineralization (8 to 14 meters in length).

CanAlaska Uranium Ltd. (CVVUF), closed Wednesday's trading session at $0.1732, up 2.36%, on 3,750 volume with 4 trades. The average volume for the last 3 months is 13,220 and the stock's 52-week low/high is $0.1579/$0.3455.

chart

TechCare Corp. (TECR)

InvestorsHub, MarketWatch, Stockhouse, OTC Markets, Investing, 4-Traders, GuruFocus, Morningstar, YCharts, Penny Stock Tweets, PR Newswire, Investors Hangout, Seeking Alpha, Wallet Investor, Stockwatch, Barchart, last10k, Dividend Investor, Emerging Growth, and Market Screener reported earlier on TechCare Corp. (TECR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

TechCare Corp. has an inventive delivery platform that utilizes vapor technology for natural health and beauty treatments. The Company engages in the design, development, and commercialization of this unique delivery platform using vaporization of different natural, plant-based compounds, to enable a wide variety of treatment solutions. A technology company and OTCQB-listed, TechCare is based in New York City.

The Company has a strategic partnership agreement with HoMedics, one of the world's leading brands in health and wellness products. HoMedics manufactures, markets, and distributes TechCare's Novokid products in the United States, Canada, Brazil, Argentina, Colombia, and Costa Rica. These products are co-branded as HoMedics products powered by TechCare. 

Novokid consists of a portable device that vaporizes TechCare's all-natural, plant-based solution contained in a disposable capsule. It comes with a proprietary head cap. Novokid is 100 percent natural, plant-based and pesticide-free. Novokid is the first of its type home use device. It presents a scientifically proven solution to eliminate lice, super lice, as well as eggs.

Novokid uses a proprietary vapor-based delivery platform. TechCare’s Novokid has received CE Mark approval as a CLASS I Medical Device. Novokid uses a simple 10-minute dry treatment. The treatment requires no rinsing or washing and is fast, dry, and clean. It is easily administered at home or while mobile. In addition, Novokid can be used as a maintenance and preventative treatment if used regularly.

The Company’s Shine is a hair treatment device. It underwent development with globally renowned industry leaders. Shine cleanses the hair and scalp. It also rejuvenates hair by returning its natural health, shine, body and luster. The expectation is that Shine will launch later in 2019.

TechCare announced in May of 2018 that following intensive research and development (R&D) and investments, it expanded its existing Intellectual Property (IP) portfolio with a previously submitted patent application of its Smart Capsule™ technology. Building upon its existing patents and knowledge, the new Smart Capsule™ technology enables the vaporization of two or more compounds simultaneously. As a result, this expands the range of applications while yielding superior performance, usability and ease-of-use.

Last month, TechCare announced that on January 21, 2019, it entered into a joint venture (JV) contract with China-Israel Biological Technology Co. Ltd. (CIB). With this agreement, TechCare's subsidiary Novomic Ltd. and CIB agreed to create a Chinese JV company in China.

The JV will concentrate on the field of health and cosmetics, including medical care, home care, hair care, and body and skin care, to develop a comprehensive and extensive range of health, wellness, beauty and home products for customers by using TechCare's patented technology of vaporization of natural and plant-based compounds. The JV’s intention is to sell its products in the Greater China region, including mainland China, Hong Kong, Macao and Taiwan, directly or through others.

TechCare Corp. (TECR), closed Wednesday's trading session at $0.145, up 3.50%, on 319 volume with 2 trades. The average volume for the last 3 months is 11,879 and the stock's 52-week low/high is $0.0401/$0.75.

chart

American Green, Inc. (ERBB)

Insider Financial, Best Medical Marijuana Stocks, Morningstar, YCharts, Daily Marijuana Observer, InvestorsHub, Wall Street Alerts, Guru Focus, MarketWatch, Stockhouse, otc.watch, Wallet Investor, Seeking Alpha, Market Screener, Awesome Penny Stocks, New Cannabis Ventures, Barchart, and Marijuana Stocks reported earlier on American Green, Inc. (ERBB), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

American Green, Inc. operates the U.S. as a technology company in the medical cannabis industry. It became one of the first publicly traded technology companies in the medical cannabis industry globally, beginning in 2009, with the introduction of the ZaZZZ machine for automated, age-verifying dispensing of cannabis-based medicines. American Green’s dedication is to the developing cannabis market. The Company is based in Phoenix, Arizona.

American Green has its AGM verified vending system. The Company enables businesses to securely vend age-restricted products. This includes cannabis, beer, tobacco, pharmaceuticals, and more.

American Green has a state-of-the-art cultivation facility in Phoenix. Furthermore, it is involved with the sale or creation of a number of apps supporting cannabis and small businesses alike. This includes the Blaze Now dispensary locator that can be found in the Apple and Android app stores, as well as the Company’s Xpress app.

In September 2017, American Green purchased the desert town of Nipton, California. In October, it announced that it completed Phase One of its integration into Nipton. The Company’s stated goal for the town's future is for it to become the first energy-independent cannabis-friendly town in America. The new focus for the Town of Nipton is as a host location for cannabis tourism and a center for art and nature educational workshops.

American Green entered into a Joint Venture (JV) to form a CBD processing plant in Nipton with MediaTechnics Corporation (MEDT). With this JV, MEDT is to specify, procure, design, develop and install a state-of-the-art extraction facility in Nipton that can extract Cannabidiol (CBD) from Industrial Hemp.

American Green also completed its acquisition of Delta International Oil and Gas (DLTZ) through the sale of its Nipton assets. As a result, American Green gained control of Delta. Delta operates as a subsidiary of American Green. The expectation is that Delta International will invest heavily in Nipton and other American Green-run projects.

American Green announced in June 2018 that its state-of-the-art, 12,000 square foot medical cannabis grow facility opened in Phoenix. The facility commenced operations immediately. All products produced sell through American Green’s licensed grow partner, Natural Herbal Remedies.

American Green announced in 2018 that it entered into a Memorandum of Understanding (MOU) to create American Green Films, LLC. This is to produce commercial motion pictures, the first of which will use Nipton as its central location.

American Green announced in August of 2018 that its subsidiary, Delta International Oil & Gas, changed its name to CannAwake Corporation with the new stock symbol (CANX). American Green and CannAwake have completed the purchase of the solar power generating station in Nipton, California.

Last month, American Green announced that the cannabis grow operation it manages for its Licensee, Natural Herbal Remedies, was anticipated to reach full production in January. This 12,000 sq. ft. grow operation, on the west side of Phoenix, was years in the making because of numerous State and local licensing, permitting, and building modification issues. However, according to Mr. David Gwyther, American Green’s President, “It was worth the wait. The facility, which we call “Sweet Virginia,” is now turning out some of the best cannabis in the state of Arizona!”

American Green, Inc. (ERBB), closed Wednesday's trading session at $0.0003, up 50.00%, on 14,484,969 volume with 56 trades. The average volume for the last 3 months is 91,650,539 and the stock's 52-week low/high is $0.000197/$0.00109.

chart

School Specialty, Inc. (SCOO)

NetworkNewsWire, Wallet Investor, GlobeNewswire, Zacks, Marketbeat, Wallmine, Trading View, Simply Wall St, Capital Cube, Stockhouse, Morningstar, and MarketWatch reported previously on School Specialty, Inc. (SCOO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

School Specialty, Inc. is a foremost provider of unique products and solutions, which support integrated learning environments for improved student social, emotional, mental and physical well-being. The Company serves teachers, curriculum specialists, individual schools, school districts, and parents, as well as administrators in different healthcare related markets. Established in 1959 and OTCQB-listed, School Specialty is headquartered in Greenville, Wisconsin.

School Specialty designs, develops and delivers the widest array of innovative and proprietary products, programs and services to the education marketplace. These include essential classroom supplies, furniture, educational technology, supplemental learning resources, science-based curriculum, and evidence-based safety training & security. The Company serves the United States and Canada by way of a comprehensive network of distribution centers powered by a multi-channel approach.

School Specialty offers its own proprietary products from best-in-class brands like Sax, SSI Guardian, Frey, Foss and School Smart, and also some of the most trusted third-party brands in the educational market. School Specialty has grown into a company that includes greater than 70 subject matter experts and other industry thought leaders always seeking out and sharing leading edge ideas to advance modern education.

In December of 2018, School Specialty announced that the Full Option Science System™ (FOSS®) was adopted by the California State Board of Education (SBE) for the 2018 Science Instructional Materials Adoption. As part of School Specialty’s Delta Education offering for science curriculum and resources, FOSS is the top active-learning science program in the U.S. The California SBE selected FOSS Next Generation™ for adoption by school districts at the K-5 and 6-8 grade levels.

Last month, School Specialty provided results for its fiscal Q1 ended March 30, 2019 and reiterated fiscal 2019 EBITDA guidance. Mr. Michael Buenzow, Interim Chief Executive Officer, stated, “While early first quarter bookings were lower-than-expected, we exited March with solid momentum. Our year-to-date orders are now showing growth as we seek to maximize our realigned market coverage model combined with a favorable industry backdrop. Based on strong booking trends and the traction we are making with key large districts across the country as we begin to realize leverage from our team-sell model, we are expecting a strong peak season and remain on track to meet our full-year EBITDA guidance.”

Q1 Fiscal 2019 results include Revenue of $95.9 million for the quarter ended March 30, 2019, versus $99.3 million in the first quarter of fiscal 2018. This represents a decrease of 3.4 percent. School Specialty reported an adjusted earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) loss of roughly $13.9 million for the quarter ended March 30, 2019 versus a loss of $12.0 million in the quarter ended March 31, 2018. The year-over-year decline was mainly related to a $1.8 million shift in catalog production from late 2018 into Q1 of 2019.

School Specialty, Inc. (SCOO), closed Wednesday's trading session at $5.40, even for the day, on 2,785 volume with 3 trades. The average volume for the last 3 months is 5,679 and the stock's 52-week low/high is $5.35/$20.02.

chart

The QualityStocks Company Corner

INmune Bio Inc. (NASDAQ: INMB)

The QualityStocks Daily Newsletter would like to spotlight INmune Bio Inc. (NASDAQ: INMB).

INmune Bio Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, on Tuesday announced that its director of neuroscience, CJ Barnum, Ph.D., will be giving a scientific talk and presenting a poster on Alzheimer’s drug candidate XPro1595 at the TNF Conference on June 4, 2019. To view the full press release, visit http://nnw.fm/m51wG.

INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient's innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer's disease. INmune Bio's product platforms utilize a precision therapy approach to promote the body's innate immune response to treat unsolved problems in medicine.

INmune Bio is the first biotechnology company to close an initial public offering (IPO) in 2019 and commence trading on The Nasdaq Capital Market. The company also received a "Part the Cloud" award from the Alzheimer's Association in 2018 which included a $1 million grant to advance INmune Bio's XPro1595 drug candidate.

INmune Bio's product pipeline targets three segments of concern:

  • Alzheimer's disease/dementia claims 5.5 million patients in the United States. INmune Bio views Alzheimer's as an immunologic disease which changes the drug discovery process, changes the way clinical trials are designed, and may provide hope for patients and caregivers.
  • Cancer residual disease which is expected to generate more than 1.7 million new cases yearly with an estimated 609,640 fatalities. INMB believe that converting resting Natural Killer ("NK") cells to primed NK cells, which kill cancerous cells on contact, is an important therapeutic strategy to help clear residual disease.
  • Resistance to immunotherapy. By preventing the proliferation and function of cells that resist immunotherapy, patients should have a stronger immune response to cancer cells and may respond better to other cancer treatments including immunotherapy and live longer.

INmune Bio Drug Candidates and Clinical Programs

INKmune is a biologic delivery system that primes a patient's resting NK cells to kill cancer. INKmune targets residual disease for patients that have completed initial cancer therapy (surgery, radiation and/or chemotherapy) and have a low burden of disease with a high risk of relapse.

In late 2019, INKmune will start enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer. In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of the patients own NK cells to eliminate minimal residual disease ("MRD").

Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.

INB03 is a checkpoint inhibitor that targets myeloid derived suppressor cells ("MDSC") which can produce an immunosuppressive shield that prevents a patient's own immune system from attacking the cancer. INmune Bio is currently completing a monotherapy INB03 phase I trial in patients with advanced solid tumors. The INB03 program will transition into a combination therapy clinical program in the summer of 2019 to prepare for a phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC.

Treatment with INB03 should eliminate MDSC in the tumor microenvironment to allow checkpoint inhibitors to be therapeutically effective.

XPro1595 targets the microglial immune cells of the brain that are activated in many Alzheimer's disease patients. These microglial cells are a cause of neuroinflammation that can kill nerve cells and promote synaptic dysfunction – the cause of dementia in Alzheimer's.

The three-month, phase I trial is expected to enroll 18 patients in summer of 2019. It is designed to measure traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer's disease who have neuroinflammation. The trial is supported by a $1 million "Part the Cloud" grant from the Alzheimer's Association. Inflammation, especially chronic inflammation, is being recognized as an important part of the pathology of many diseases including cancer and Alzheimer's disease.

Management

Dr. RJ Tesi, M.D., INmune Bio co-founder, CEO and acting chief medical officer, has been a licensed physician since 1982 and a Fellow of the American College of Surgery since 1991. He received his medical degree from Washington University School of Medicine in 1982 and has served many roles in several development-stage biotech companies focused on treatment of neurodegenerative diseases, hematologic malignancies, and other inflammatory diseases.

CFO David J. Moss co-founder, has been with the company since its formation in September 2015. He holds an MBA from Rice University and a bachelor's degree in economics from the University of California, San Diego. Moss has founded, funded and taken public various companies in a variety of industries since 1995.

Mark Lowdell, Ph.D. co-founder, has served as the chief scientific officer and chief manufacturing officer at INmune Bio since the company's formation. He is a professor of cell and tissue therapy at University College London where he has led a translational immunotherapy group since 1994. He has also been a director of cellular therapy at the Royal Free London NHS Foundation Trust. He received his Ph.D. in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.

Christopher J. Barnum is director of neuroscience at INmune Bio. Barnum is a neuroimmunologist with broad expertise across neurodegenerative and psychiatric diseases holding multiple positions in academic and industry. His focus has been on translating inflammatory therapies into clinical treatments for neurologic diseases using a biomarker-directed approach. Barnum's research has been supported by the NIH, the Michael J. Fox Foundation, and the Alzheimer's Association. He received his Ph.D. in neuroscience from Binghamton University.

INmune Bio Inc. (OTC: INMB), closed the day's trading session at $10.46, up 1.84%, on 10,372 volume with 82 trades. The average volume for the last 3 months is 17,820 and the stock's 52-week low/high is $7.00/$11.50.

Recent News

chart

Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

Geyser Brands Inc. (TSX.V: GYSR) has recently announced an acquisition that provides the company with two brands of hemp and CBD products. As the hemp and CBD markets grow, a wide variety of CBD- and hemp-based products are becoming available, including products for pets.

Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.

NanoFusion Technology

The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.

Operations

Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

Among the brand formulations in Geyser Brand's portfolio are:

  • Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
  • Prohibition Cold Brew Mocha designed with water soluble hemp molecules
  • Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
  • Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control

Management Team

Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.

CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.

Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.

Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed the day's trading session at $0.65, up 6.56%, on 3,000 volume with 2 trades. The average volume for the last 3 months is 8,946 and the stock's 52-week low/high is $0.55/$0.85.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Florida-based biotech company Earth Science Tech (OTCQB: ETST) recently began an informercial campaign that tells the real-life story of the impact of ETST cannabinoids on a consumer. To view the full article, visit: http://nnw.fm/951tV.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.505, up 12.22%, on 38,449 volume with 26 trades. The average volume for the last 3 months is 35,162 and the stock's 52-week low/high is $0.3009/$2.45.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services for the medical and adult-use markets and licensed producer of cannabis under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited and ABcann Medicinals Inc., and its medical cannabis clinic network operated by Harvest Medicine Inc., today announced the results of its annual general and special meeting of shareholders held on June 4, 2019 (the "Meeting").

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.467, up 0.41%, on 34,857 volume with 47 trades. The average volume for the last 3 months is 243,679 and the stock's 52-week low/high is $0.413/$1.53.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions (OTCQB: SGSI), a leading telecommunications engineering and infrastructure services provider, recently reported its first quarter with positive income from operations. To view the full article, visit: http://nnw.fm/1uXcT.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed the day's trading session at $0.14, up 10.15%, on 24,051 volume with 7 trades. The average volume for the last 3 months is 93,863 and the stock's 52-week low/high is $0.071/$2.59.

Recent News

chart

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)

The QualityStocks Daily Newsletter would like to spotlight Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN).

Black Iron Inc. (TSX: BKI; OTC: BKIRF; FRANKFURT: BIN), as part of providing reassurance to potential investors regarding project construction, has renewed its letter of intent (“LOI”) with TransInvestServis (“TIS”) for storage and cape-size ship loading capacity of up to 8.0 Mtpa (+/-15%) at TIS’ privately owned berth at Port Yuzhny to match the projected production from the phased build of Black Iron’s Shymanivske Project (the “Project”). Black Iron has also renewed its LOI with DTEK DNIPRO GRIDS JSC (“DTEK”) to secure the electricity power required to operate the mine and processing plant.

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.

The Market

Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (http://nnw.fm/2vaDR).

Countries around the world, most notably China (http://nnw.fm/Je8gs), have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.

Shymanivske Project

Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.

The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database (http://nnw.fm/3MXsT). This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.

Black Iron continues to advance its project on several fronts including construction funding and off-take agreements (http://nnw.fm/tQ4g2). Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.

The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.

Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?www.sedar.com.

Management

Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.

Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.

Black Iron Inc. (BKIRF), closed the day's trading session at $0.075, up 6.99%, on 13,900 volume with 4 trades. The average volume for the last 3 months is 31,332 and the stock's 52-week low/high is $0.0285/$0.0891.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Clinical-stage, gene-therapy company Genprex (NASDAQ: GNPX) is developing Oncoprex immunogene therapy as an innovative, gene therapy-based approach for the treatment of non-small cell lung cancer (“NSCLC”). To view the full article, visit: http://nnw.fm/49tGC.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed the day's trading session at $1.38, off by 8.00%, on 56,075 volume with 186 trades. The average volume for the last 3 months is 48,284 and the stock's 52-week low/high is $0.95/$11.19.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), announced today the opening of its innovative demonstration center to visitors. The QuadSight™ demonstration center is located near Foresight's offices, giving customers, business partners and investors an opportunity to ride in a vehicle equipped with Foresight's automotive vision system. Also today, NetworkNewsWire released a report on the company detailing how FRSX recently announced the opening of its innovative demonstration center. Per the update, the QuadSight demonstration center, located near the company's offices, provides investors, customers and business partners with the opportunity to ride in a vehicle that’s equipped with Foresight’s automotive vision system. To view the full press release, visit http://nnw.fm/F8Wgu.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $0.9099, off by 2.68%, on 7,502 volume with 33 trades. The average volume for the last 3 months is 56,915 and the stock's 52-week low/high is $0.839/$4.43.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly" or the “Company”) is pleased to announce that through its wholly owned subsidiary Toronto Herbal Remedies Inc (“THR”), has submitted an amendment for a sales license for cannabis flower.  THR has successfully completed its first packaging run for cannabis flower product and has provided all supporting documents to Health Canada.  Following a “compliant” rating after their last inspection earlier this year, THR is now looking forward to their next visit from Health Canada in anticipation of receipt of their sales license.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.546, off by 2.11%, on 163,445 volume with 93 trades. The average volume for the last 3 months is 796,503 and the stock's 52-week low/high is $0.189/$1.875.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF), was the feature of an article on Hempsley.com titled ‘Introducing: Wildflower’. Hempsley is teaming up with Wildflower to give customers a CBD experience free of fertilizers and pesticides. To view the full article, visit: http://nnw.fm/SnNj5. Also today, CannabisNewsWire released a report on the company detailing how WLDFF has raised the public profile of CBD through celebrity associations and entry into prestige shops.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.48, off by 1.09%, on 18,595 volume with 18 trades. The average volume for the last 3 months is 22,949 and the stock's 52-week low/high is $0.009/$1.129.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

To meet the vital communication needs of first responders, Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) leveraged its strong commercial experience in mission-critical communications systems and launched its FirstNet Ready Uniden® UV350, the first-to-market, in-vehicle device of its kind.

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed the day's trading session at $0.343, off by 2.00%, on 24,630 volume with 8 trades. The average volume for the last 3 months is 64,094 and the stock's 52-week low/high is $0.254/$0.4462.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals Corp. (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ) was featured today in an article from NetworkNewsWire. Lithium is well known by consumers as being a necessary component of rechargeable lithium-ion batteries, which are essential to power electric vehicles and other smart, mobile devices. A recent report by Global Market Insights projects that the global lithium-ion battery market will surpass $60 billion by 2024 as the growing adoption of electric vehicles, coupled with government initiatives to promote sustainable, green technology, boosts the lithium sector (http://nnw.fm/8Jz80).

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.15, off by 5.36%, on 23,781 volume with 11 trades. The average volume for the last 3 months is 55,242 and the stock's 52-week low/high is $0.1155/$0.44.

Recent News

chart

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions, Inc. (OTCMKTS: DVLP) (“DVLP” or the “Company”), an emerging leader in the Cannabis, Hemp, and CBD marketplace, is pleased to announce that the Company will be officially moving into its new 25,000 square-foot production facility in Denver, CO, on June 10, 2019.

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.0166, off by 5.95%, on 4,108,304 volume with 159 trades. The average volume for the last 3 months is 3,905,353 and the stock's 52-week low/high is $0.0122/$0.14.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Emerging technology cultivator SinglePoint Inc. (OTCQB: SING) is launching a national distribution program that fosters the retail network aspirations of fast-growing cannabidiol (CBD) product companies to get their products into consumers’ hands. The ‘Strategics’ program will provide qualifying companies, with annual revenue above $2 million, a pathway to market through a national distribution partner that has nearly $2 billion in annual sales to mass-market stores such as CVS, Walgreens, Rite-Aid, Dollar General, Dollar Tree, Giant Eagle, Meijer and Kroger grocery stores, as well as a wide number of regional and national convenience stores.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0116, off by 1.69%, on 2,924,088 volume with 90 trades. The average volume for the last 3 months is 3,851,202 and the stock's 52-week low/high is $0.0106/$0.068.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.